Lv1
50 积分 2025-04-07 加入
Matching-adjusted Indirect Comparison of Current Treatments for NMOSD and Evaluation of Long-term Effectiveness
9小时前
待确认
GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
11小时前
已完结
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
4个月前
已完结
皖公网安备34019202002308
